Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, May 14, 2021
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
Thu, May 13, 2021
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
[ Thu, May 13th 2021
] - WOPRAI
Vikram Purohit Maintained (TBPH) at Buy with Decreased Target to $28 on, May 13th, 2021
Vikram Purohit of Morgan Stanley, Maintained "Theravance Biopharma, Inc." (TBPH) at Buy with Decreased Target from $30 to $28 on, May 13th, 2021.
Vikram has made no other calls on TBPH in the last 4 months.
There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 0 agree with Vikram's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Vikram
- Geoffrey Porges of "SVB Leerink" Maintained at Buy with Decreased Target to $39 on, Wednesday, May 5th, 2021
- Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $32 on, Wednesday, May 5th, 2021
